Latest news
enVVe Venous Valve Trial Expected to Enroll About 230 Patients - Stock TitanStock Titan · Fri, 31 Jul 2026 12:30:00 GMTRecovryAI Completes Patient Phase of Pivotal Trial Evaluating Its Clinical AI in Advance of FDA De Novo Filing - Business WireBusiness Wire · Thu, 30 Jul 2026 16:28:00 GMTClaris Bio Unveils Development Strategy, Planned Pivotal Study Supported by $118 Million Series B Financing from Top-Tier Investors, and Multiple Leadership Appointments - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 07:00:00 GMT